Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spruce Biosciences Inc (NQ: SPRB )

0.7032 +0.0032 (+0.46%)
Streaming Delayed Price Updated: 3:46 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 169,262
Open 0.7100
Bid (Size) 0.7032 (2)
Ask (Size) 0.7065 (6)
Prev. Close 0.7000
Today's Range 0.6977 - 0.7101
52wk Range 0.6711 - 5.950
Shares Outstanding 40,710,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Performance

YTD
-76.24%
-76.24%
1 Month
+0.46%
+0.46%
3 Month
-76.94%
-76.94%
6 Month
-34.28%
-34.28%
1 Year
-66.19%
-66.19%

More News

Read More
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
Via Benzinga
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
US Stocks Higher; Producer Prices Rise 0.6% In February
Via Benzinga
Topics Stocks
Exposures US Equities
Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
Via InvestorPlace
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Fisker (FSR) Stock Down 41% Today?
Via InvestorPlace
Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?
Via InvestorPlace
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
From Spruce Biosciences, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
From Spruce Biosciences, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.